文献速递湿疹皮炎与荨麻疹银屑病与炎症性皮肤病

扁平苔藓药物治疗的综合循证分析

Lichen planus: a comprehensive evidence-based analysis of medical treatment.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-07-22

该综述通过MEDLINE和PubMed检索扁平苔藓(LP)治疗文献,共纳入219篇(16%)分析21种治疗方式。局部外用糖皮质激素和钙调神经磷酸酶抑制剂证据质量高,为当前一线治疗;口服糖皮质激素证据质量中等,其余疗法证据质量低或极低。缺乏大型随机对照试验支持其他疗法的疗效、安全性和耐受性。

要点

  • 局部外用糖皮质激素和钙调神经磷酸酶抑制剂是当前一线治疗。
  • 口服糖皮质激素证据质量中等,其他疗法证据质量低或极低。
  • 其他疗法多基于小样本、缺乏标准化结局或对照的研究,需大型随机对照试验验证。

核心结论

  • 局部外用糖皮质激素和钙调神经磷酸酶抑制剂为当前一线治疗,其他疗法推荐强度不明确。

研究设计与样本

  • 通过MEDLINE和PubMed数据库检索扁平苔藓治疗相关文献,共检索1366篇,最终纳入219篇(16%)进行证据质量分级分析。

主要发现

  • 共分析21种不同治疗方式。
  • 局部外用糖皮质激素和钙调神经磷酸酶抑制剂的证据质量高,口服糖皮质激素证据质量中等,其余疗法证据质量低或极低。

关键数值与推荐

  • 局部外用糖皮质激素和钙调神经磷酸酶抑制剂证据质量高且为一线治疗;口服糖皮质激素证据质量中等;其他疗法证据质量低或极低。

临床怎么用

  • 临床可优先选用局部外用糖皮质激素和钙调神经磷酸酶抑制剂治疗扁平苔藓。
  • 对其他疗法应认识到其证据强度不足,需结合个体情况谨慎使用。

局限性

  • 缺乏支持其他疗法疗效、安全性和耐受性的大型随机对照试验。
  • 许多疗法基于小样本研究、缺乏标准化结局指标、缺乏对照持续时间或仅为 anecdotal 证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lichen planus (LP) is a chronic-relapsing inflammatory skin disease. Although many drugs have been used for the management of LP, some of them lack the backup by strong therapeutic evidence, while others are not suitable for some patients due to safety profile issues. The aim of this study was to review the recent status of available medical therapies for LP to help physicians make better decisions upon best medical practice while facing patients with this condition. A review of published articles on management of LP was conducted with the MEDLINE and PubMed databases. The quality of the evidence was graded as high, moderate, low or very low. A total of 1366 articles were retrieved, and 219 (16%) were included in the final analysis. Twenty-one different treatment modalities were analysed. The quality of evidence was high for topical steroid and calcineurin inhibitor, while it was moderate for oral steroids. All the other modalities reached low or very low quality of evidence. Topical steroids and calcineurin inhibitors are the current first-line therapies, while for other therapies the strength of recommendation is not so evident. Unfortunately, larger randomized, controlled trials to support the efficacy, safety and tolerability of other therapies in LP are lacking, and many of them are recommended based on studies with small sample sizes, lack of standardized outcome measures or lack of controlled duration or even in anecdotal evidence. Thus, large-scale randomized clinical trials are still warranted to establish the exact benefits of other topical treatments, phototherapy, immunosuppressant and new immunomodulators for an optimized treatment of LP.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Husein-ElAhmed H, Gieler U, Steinhoff M, et al. Lichen planus: a comprehensive evidence-based analysis of medical treatment. J Eur Acad Dermatol Venereol. 2019. PMID: 31265737. doi:10.1111/jdv.15771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。